Evidence map›Paper›PMID 41972045›Full record

ArticleQuantitative imaging in medicine and surgery2026

Establishment of prediction model for breast lesion using automated breast ultrasound system.

Xing Wang, Xinguang Wang, Xinyi Wang, Yingjian He, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Ling Huo, Tao Ouyang

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xing Wang *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, China.
Xinguang Wang *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, China.
Xinyi Wang *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, China.
Yingjian HeKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, China.
Jinfeng LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, China.
Tianfeng WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, China.
Zhaoqing FanKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, China.
Ling HuoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, China.
Tao OuyangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Automated breast ultrasound systems (ABUS) have been increasingly used for breast lesion detection; however, standardized and interpretable prediction models based on ABUS lexicon features for differentiating benign from malignant lesions remain limited. Therefore, this study aimed to establish a prediction model that differentiates malignant from benign breast lesions using an ABUS. Methods: This prospective study enrolled patients with single breast lesions identified by handheld ultrasound (HHUS) in Peking University Cancer Hospital between June 2010 and December 2012. The ABUS was performed and the ultrasonic features were described based on the fifth edition of the Breast Imaging Reporting and Data System (BI-RADS) ultrasound lexicon and related literature of lesions and a pathology examination was performed to confirm pathological status. The model performance was evaluated using the area under the curve (AUC). Results: There were 2,090 patients with single breast lesions included and 630 cases (30.1%) were selected for pre-test. Patients were then randomly split 1:1 into a training set (n=315) and a validation set (n=315). Univariate analysis revealed that lesion form, shape, orientation, margin, boundary, and posterior acoustic feature were significantly different between the benign lesion and malignant lesion group (all P<0.05). The lesion form, boundary, and margin were further selected for multivariate model development. The equation was Y=1.604 × boundary + 1.045 × lesion form - 5.436 × margin (A) - 2.166 × margin (B), the AUC reached 0.882 [95% confidence interval (CI): 0.844-0.919] in training set and 0.866 (95% CI: 0.824-0.928) in validation set. Conclusions: Lesion form, boundary, and margin information might be associated with benign and malignant lesions on ABUS. The malignant lesion prediction model based on lesion form, boundary, and margin showed great diagnostic performance in both training and validation cohorts.

Indexed as

automated breast ultrasound system (ABUS)Breast lesionshandheld ultrasound (HHUS)multivariate logistic regressionprediction model

Identifiers

PMID41972045
PMCPMC13066849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.